These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38675974)

  • 1. SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells.
    Antia A; Alvarado DM; Zeng Q; Casorla-Perez LA; Davis DL; Sonnek NM; Ciorba MA; Ding S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
    Meng B; Abdullahi A; Ferreira IATM; Goonawardane N; Saito A; Kimura I; Yamasoba D; Gerber PP; Fatihi S; Rathore S; Zepeda SK; Papa G; Kemp SA; Ikeda T; Toyoda M; Tan TS; Kuramochi J; Mitsunaga S; Ueno T; Shirakawa K; Takaori-Kondo A; Brevini T; Mallery DL; Charles OJ; ; ; ; Bowen JE; Joshi A; Walls AC; Jackson L; Martin D; Smith KGC; Bradley J; Briggs JAG; Choi J; Madissoon E; Meyer KB; Mlcochova P; Ceron-Gutierrez L; Doffinger R; Teichmann SA; Fisher AJ; Pizzuto MS; de Marco A; Corti D; Hosmillo M; Lee JH; James LC; Thukral L; Veesler D; Sigal A; Sampaziotis F; Goodfellow IG; Matheson NJ; Sato K; Gupta RK
    Nature; 2022 Mar; 603(7902):706-714. PubMed ID: 35104837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
    Richardson SI; Mzindle N; Motlou T; Manamela NP; van der Mescht MA; Lambson BE; Everatt J; Amoako DG; Balla S; von Gottberg A; Wolter N; de Beer Z; de Villiers TR; Bodenstein A; van den Berg G; Abdullah F; Rossouw TM; Boswell MT; Ueckermann V; Bhiman JN; Moore PL
    J Virol; 2024 Jul; 98(7):e0067824. PubMed ID: 38953380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ; Shapiro C; Isidro MGD; Bradley P; Pragalos A; Bloch M; Santiaguel J; Frias MV; Miyakis S; Alves de Mesquita M; Berrè S; Servais C; Waugh N; Hoffmann C; Baba E; Schönborn-Kellenberger O; Wolz OO; Koch SD; Ganyani T; Boutet P; Mann P; Mueller SO; Ramanathan R; Gaudinski MR; Vanhoutte N
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408863. PubMed ID: 39422261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice.
    Sangare K; Liu S; Selvaraj P; Stauft CB; Starost MF; Wang TT
    mSphere; 2024 Dec; ():e0072624. PubMed ID: 39660912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
    Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
    Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape.
    Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.
    Kakizaki M; Hashimoto R; Nagata N; Yamamoto T; Okura T; Katoh H; Kitai Y; Akahori Y; Shirato K; Ryo A; Takayama K; Takeda M
    J Virol; 2024 Nov; ():e0185324. PubMed ID: 39601592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird among Omicron Sublineages.
    Ray SK; Mukherjee S
    Infect Disord Drug Targets; 2025; 25(1):e270624231369. PubMed ID: 38939989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023.
    Arantes I; Ito K; Gomes M; Carvalho FCd; Ferreira de Almeida WA; Khouri R; Miyajima F; Wallau GL; Naveca FG; Pereira EC; ; Mendonça Siqueira M; Resende PC; Bello G
    Microbiol Spectr; 2024 Nov; ():e0119324. PubMed ID: 39611827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature impacts SARS-CoV-2 spike fusogenicity and evolution.
    Dufloo J; Sanjuán R
    mBio; 2024 Apr; 15(4):e0336023. PubMed ID: 38411986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.
    Starr TN; Greaney AJ; Stewart CM; Walls AC; Hannon WW; Veesler D; Bloom JD
    PLoS Pathog; 2022 Nov; 18(11):e1010951. PubMed ID: 36399443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominance of SARS-CoV-2 Delta AY.33 sublineage and Omicron BA.1.1 sublineage in Erbil City/Kurdistan Region of Iraq.
    Abdulaziz SM; Ghareeb AA; Rahman MO; Haji SH
    Cell Mol Biol (Noisy-le-grand); 2024 Nov; 70(10):83-90. PubMed ID: 39605120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Nana AJ; Blumberg L; Welch R; Ngorima-Mabhena N; Mutevedzi PC
    N Engl J Med; 2022 Apr; 386(14):1314-1326. PubMed ID: 35196424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning.
    Meehan GR; Herder V; Allan J; Huang X; Kerr K; Mendonca DC; Ilia G; Wright DW; Nomikou K; Gu Q; Molina Arias S; Hansmann F; Hardas A; Attipa C; De Lorenzo G; Cowton V; Upfold N; Palmalux N; Brown JC; Barclay WS; Filipe ADS; Furnon W; Patel AH; Palmarini M
    PLoS Pathog; 2023 Nov; 19(11):e1011589. PubMed ID: 37934791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Into the Cauldron of the Variant Soup: Insights into the Molecular Epidemiology and Transition to Endemicity of SARS-CoV-2 in Cyprus (November 2022-February 2024).
    Chrysostomou AC; The Comessar Network ; Kostrikis LG
    Viruses; 2024 Oct; 16(11):. PubMed ID: 39599801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.
    Tegally H; Moir M; Everatt J; Giovanetti M; Scheepers C; Wilkinson E; Subramoney K; Makatini Z; Moyo S; Amoako DG; Baxter C; Althaus CL; Anyaneji UJ; Kekana D; Viana R; Giandhari J; Lessells RJ; Maponga T; Maruapula D; Choga W; Matshaba M; Mbulawa MB; Msomi N; ; Naidoo Y; Pillay S; Sanko TJ; San JE; Scott L; Singh L; Magini NA; Smith-Lawrence P; Stevens W; Dor G; Tshiabuila D; Wolter N; Preiser W; Treurnicht FK; Venter M; Chiloane G; McIntyre C; O'Toole A; Ruis C; Peacock TP; Roemer C; Kosakovsky Pond SL; Williamson C; Pybus OG; Bhiman JN; Glass A; Martin DP; Jackson B; Rambaut A; Laguda-Akingba O; Gaseitsiwe S; von Gottberg A; de Oliveira T
    Nat Med; 2022 Sep; 28(9):1785-1790. PubMed ID: 35760080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
    Alves RPDS; Wang YT; Mikulski Z; McArdle S; Shafee N; Valentine KM; Miller R; Verma SK; Batiz FAS; Maule E; Nguyen MN; Timis J; Mann C; Zandonatti M; Alarcon S; Rowe J; Kronenberg M; Weiskopf D; Sette A; Hastie K; Saphire EO; Festin S; Kim K; Shresta S
    Antiviral Res; 2023 Apr; 212():105580. PubMed ID: 36940916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic study of the transmission pattern of the SARS-CoV-2 omicron variant.
    An K; Yang X; Luo M; Yan J; Xu P; Zhang H; Li Y; Wu S; Warshel A; Bai C
    Proteins; 2024 Jun; 92(6):705-719. PubMed ID: 38183172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant.
    Khan K; Lustig G; Römer C; Reedoy K; Jule Z; Karim F; Ganga Y; Bernstein M; Baig Z; Jackson L; Mahlangu B; Mnguni A; Nzimande A; Stock N; Kekana D; Ntozini B; van Deventer C; Marshall T; Manickchund N; Gosnell BI; Lessells RJ; Karim QA; Abdool Karim SS; Moosa MS; de Oliveira T; von Gottberg A; Wolter N; Neher RA; Sigal A
    Nat Commun; 2023 Dec; 14(1):8078. PubMed ID: 38057313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.